Product image of Levocomp (Carbidopa, Levodopa) supplied by GNH India

Levocomp

Active Ingredient:
Carbidopa, Levodopa
Origin:
EU

Levocomp (Carbidopa, Levodopa)

Carbidopa/Levodopa, the active ingredient in Levocomp, is an Antiparkinson agent presented as an oral tablet for oral use. It is used to manage symptoms of Parkinson's disease and related Parkinsonian syndromes in adult patients. The combination works by increasing central dopamine levels while reducing peripheral side effects.

GNH India supplies Levocomp as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards and provides regulatory documentation to support import and distribution globally.

Manufacturer / TM Owner

Hexal Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levocomp, a carbidopa/levodopa combination, is employed in the management of Parkinsonian movement disorders.

  • Parkinson's disease: Improves motor symptoms such as bradykinesia, rigidity, and tremor.
  • Parkinsonian syndrome: Reduces stiffness and improves gait in secondary Parkinsonism.
  • Motor fluctuations in Parkinson's disease: Helps smooth out “on‑off” periods and prolongs the therapeutic response.

How It Works

  • Carbidopa/levodopa works by delivering levodopa, a dopamine precursor, across the blood‑brain barrier where it is converted to dopamine. Carbidopa inhibits peripheral aromatic L‑amino acid decarboxylase, preventing premature conversion of levodopa outside the central nervous system, thereby increasing central dopamine availability and minimizing peripheral side effects.

Side Effects

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Orthostatic hypotension: dizziness upon standing.
  • Headache: transient cranial discomfort.
  • Insomnia: difficulty initiating sleep.
  • Dyspepsia: indigestion or abdominal discomfort.

Serious or Rare Side Effects

  • Dyskinesia: involuntary, erratic movements.
  • Hallucinations: visual or auditory perceptual disturbances.
  • Severe hypotension: marked blood pressure drop requiring medical attention.
  • Cardiac arrhythmias: irregular heart rhythms.
  • Neuroleptic malignant syndrome: rare but life‑threatening reaction.

Precautions & Warnings

Levocomp should be used with careful clinical monitoring and patient education.

  • Monitor blood pressure: watch for orthostatic hypotension, especially after dose initiation.
  • Assess psychiatric status: be alert for hallucinations or confusion.
  • Adjust dose in renal impairment: reduced clearance may increase exposure.
  • Avoid abrupt discontinuation: taper gradually to prevent withdrawal syndrome.
  • Use with caution in elderly patients: increased sensitivity to side effects.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Avoid Interactions

Levocomp may interact with several drug classes; clinicians should review patient medication lists.

Major Interactions (Avoid)

  • Non‑selective MAO inhibitors: risk of hypertensive crisis.
  • Antipsychotics (dopamine antagonists): may diminish therapeutic effect.
  • Pyridoxine (vitamin B6) high doses: accelerates peripheral levodopa metabolism.

Moderate Interactions (Monitor Closely)

  • Antihypertensive agents: additive blood‑pressure lowering.
  • SSRIs and SNRIs: potential for serotonin syndrome.
  • Iron or calcium supplements: may reduce levodopa absorption if taken concurrently.
  • Anticholinergics: may increase central side effects.
  • Proton‑pump inhibitors: possible alteration of gastric pH affecting absorption.

Frequently Asked Questions

Levocomp contains the combination of carbidopa and levodopa and is prescribed to treat the motor symptoms of Parkinson's disease and other Parkinsonian syndromes. It helps improve movement, reduce rigidity, and control tremor in adult patients.

Levodopa is a precursor that crosses the blood‑brain barrier and is converted into dopamine, the neurotransmitter deficient in Parkinson's disease. Carbidopa blocks the peripheral enzyme that would otherwise convert levodopa before it reaches the brain, thereby increasing central dopamine levels and reducing peripheral side effects.

The dose of Levocomp is individualized by the prescribing clinician based on disease severity, patient response, and tolerability. The prescriber determines the appropriate strength, frequency, and titration schedule for each patient.

Safety of carbidopa/levodopa in pregnancy or lactation has not been definitively established. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To request Levocomp, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Levocomp combines carbidopa with levodopa, the most effective symptomatic therapy for Parkinson's disease. Compared with dopamine agonists, it generally provides stronger motor control but may have a higher risk of dyskinesia. The addition of carbidopa reduces peripheral side effects relative to levodopa alone.

Levocomp should be stored at ambient temperature, below 25 °C, in its original container to protect it from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Levocomp is taken orally, usually with a small amount of food to reduce gastrointestinal irritation. Tablets should be swallowed whole with water and not crushed or chewed unless specifically instructed by a healthcare professional.

Serious risks include the development of dyskinesia (involuntary movements), hallucinations or psychosis, severe orthostatic hypotension, and rare occurrences of neuroleptic malignant syndrome. Patients should be monitored regularly for these adverse events, especially after dose changes.

Levocomp is contraindicated in patients with known hypersensitivity to carbidopa, levodopa, or any excipients. It should also be avoided in individuals taking non‑selective MAO inhibitors or those with narrow‑angle glaucoma, as the medication may exacerbate these conditions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Carbidopa, Levodopa

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT